Boston Children's Hospital, Division of Allergy and Immunology, Harvard Medical School, Boston, MA, United States of America; Children's National Hospital, Division of Allergy and Immunology, George Washington University School of Medicine and Health Sciences, Washington DC, United States of America.
Penn State College of Medicine, Department of Pediatrics, Hershey, PA, United States of America.
Contemp Clin Trials. 2021 May;104:106334. doi: 10.1016/j.cct.2021.106334. Epub 2021 Feb 27.
BACKGROUND/AIMS: When conducting clinical trials comparing over-the-counter (OTC) medications, the wide availability of these treatments are a potential challenge to maintaining study integrity. We seek to describe adherence to a study protocol involving widely available OTC medications.
To prospectively evaluate associations between acetaminophen use and asthma in 300 children aged 1-5 years, we conducted a double blind, randomized, controlled trial where parents administered blinded forms of either acetaminophen or ibuprofen as needed to their children over a 48 week period. Written and verbal instructions encouraged the exclusive use of the blinded study medication and discouraged OTC use. Adherence was determined by evaluating the frequency of use of per-protocol blinded study medication compared to off-protocol use of OTC medications.
4195 doses of acetaminophen or ibuprofen were received by children during the study which included 3664 doses (87.3%) of blinded study medication adhering to the protocol and 531 doses (12.7%) of OTC products deviating from the protocol with better adherence among those randomized to ibuprofen as compared to acetaminophen (89.5% vs. 85.5% of doses, p < 0.01). Individually, 227 participants (75.7%) remained fully adherent by not receiving any OTC medications. Pre-study preference for either acetaminophen or ibuprofen by the participants' families was not associated with differential rates of adherence to the blinded medication.
This parallel study demonstrated greater than 85% of acetaminophen or ibuprofen doses were blinded study medications adhering to the protocol while less than 15% were OTC deviations from the protocol. This successfully implemented study design provides a template to comparatively evaluate these and other OTC medications.
背景/目的:在进行比较非处方(OTC)药物的临床试验时,这些治疗方法的广泛可及性是维护研究完整性的潜在挑战。我们旨在描述广泛使用 OTC 药物的研究方案的依从性。
为了前瞻性评估 300 名 1-5 岁儿童中使用对乙酰氨基酚与哮喘之间的关联,我们进行了一项双盲、随机、对照试验,其中父母在 48 周内根据需要为孩子服用盲法形式的对乙酰氨基酚或布洛芬。书面和口头说明鼓励仅使用盲法研究药物,并劝阻使用 OTC 药物。通过评估与方案偏离的 OTC 药物相比,符合方案的盲法研究药物的使用频率来确定依从性。
在研究期间,儿童共接受了 4195 剂对乙酰氨基酚或布洛芬,其中 3664 剂(87.3%)为符合方案的盲法研究药物,531 剂(12.7%)为偏离方案的 OTC 产品,随机分配至布洛芬组的儿童比分配至对乙酰氨基酚组的儿童具有更好的依从性(分别为 89.5%和 85.5%的剂量,p<0.01)。单独来看,227 名参与者(75.7%)完全没有接受任何 OTC 药物,完全依从。参与者家庭对乙酰氨基酚或布洛芬的预先研究偏好与盲法药物的依从率无差异。
这项平行研究表明,超过 85%的对乙酰氨基酚或布洛芬剂量为符合方案的盲法研究药物,而只有不到 15%的剂量为偏离方案的 OTC 药物。这种成功实施的研究设计为比较评估这些和其他 OTC 药物提供了模板。